Finanical Statements
Ibnsina Pharma (ISPH.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 31/03/2026
Published at 17 May 2026 at 11:49Ibnsina PharmaRelated stock:Ibnsina Pharma stockAll Ibnsina Pharma disclosures
Disclosure summary
Company Name: Ibnsina Pharma
ISIN Code: EGS512O1C012
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 246,274,405
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 176,331,444
Audit Status: Reviewed
Source: Ibnsina Pharma
The Standalone Financial Statements in English (2,593 KB)
The Standalone Financial Statements in Arabic (2,433 KB)
ISIN Code: EGS512O1C012
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 246,274,405
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 176,331,444
Audit Status: Reviewed
Source: Ibnsina Pharma
The Standalone Financial Statements in English (2,593 KB)
The Standalone Financial Statements in Arabic (2,433 KB)